Tests an eye implant with a stent for open-angle glaucoma
Tests a travoprost eye implant plus a stent in adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Travoprost Intraocular Implant + iStent Infinite
Key facts
- Where
- Oklahoma City, United StatesSee the site
- Phase
- Phase 4
Where in United States
- Oklahoma CityOklahoma City, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaukos Corporation
- Trial code
- NCT06066645
- Record updated
- 2 June 2026
- Original description
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.Read full original descriptionShow less
Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite in Subjects With Open-angle Glaucoma or Ocular Hypertension
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Inclusion: diagnosis of open-angle glaucoma or ocular hypertension; qualifying IOP in the study eye.
Exclusion: hypersensitivity to travoprost or any other components of the travoprost intraocular implant; any ocular disease or condition that, in the opinion of the investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study; unmedicated (washed out) IOP of >36 mmHg in the study eye; vertical cup/disc ratio > 0.8 in the study eye; best spectacle corrected visual acuity of worse than 20/80 in either eye.